Cysteinylation of MHC class II ligands: peptide endocytosis and reduction within APC influences T cell recognition
- PMID: 11254711
- DOI: 10.4049/jimmunol.166.7.4543
Cysteinylation of MHC class II ligands: peptide endocytosis and reduction within APC influences T cell recognition
Abstract
Peptides bind cell surface MHC class II proteins to yield complexes capable of activating CD4(+) T cells. By contrast, protein Ags require internalization and processing by APC before functional presentation. Here, T cell recognition of a short peptide in the context of class II proteins occurred only after delivery of this ligand to mature endosomal/lysosomal compartments within APC. Functional and biochemical studies revealed that a central cysteine within the peptide was cysteinylated, perturbing T cell recognition of this epitope. Internalization and processing of the modified epitope by APC, was required to restore T cell recognition. Peptide cysteinylation and reduction could occur rapidly and reversibly before MHC binding. Cysteinylation did not disrupt peptide binding to class II molecules, rather the modified peptide displayed an enhanced affinity for MHC at neutral pH. However, once the peptide was bound to class II proteins, oxidation or reduction of cysteine residues was severely limited. Cysteinylation has been shown to radically influence T cell responses to MHC class I ligands. The ability of professional APC to reductively cleave this peptide modification presumably evolved to circumvent a similar problem in MHC class II ligand recognition.
Similar articles
-
Role of APC in the selection of immunodominant T cell epitopes.J Immunol. 1999 Dec 15;163(12):6413-23. J Immunol. 1999. PMID: 10586031
-
Modification of the amino terminus of a class II epitope confers resistance to degradation by CD13 on dendritic cells and enhances presentation to T cells.J Immunol. 2000 Jan 1;164(1):129-35. doi: 10.4049/jimmunol.164.1.129. J Immunol. 2000. PMID: 10605003
-
Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions.J Immunol. 2001 Jun 1;166(11):6720-7. doi: 10.4049/jimmunol.166.11.6720. J Immunol. 2001. PMID: 11359828
-
Antigen-presenting function of B lymphocytes.Immunol Rev. 1988 Dec;106:149-80. doi: 10.1111/j.1600-065x.1988.tb00778.x. Immunol Rev. 1988. PMID: 3075588 Review.
-
Antigen-presenting cells and the selection of immunodominant epitopes.Crit Rev Immunol. 1997;17(5-6):411-7. Crit Rev Immunol. 1997. PMID: 9419428 Review.
Cited by
-
Elevation of c-MYC disrupts HLA class II-mediated immune recognition of human B cell tumors.J Immunol. 2015 Feb 15;194(4):1434-45. doi: 10.4049/jimmunol.1402382. Epub 2015 Jan 16. J Immunol. 2015. PMID: 25595783 Free PMC article.
-
Prostate Cancer Immunotherapy: Exploiting the HLA Class II Pathway in Vaccine Design.J Clin Cell Immunol. 2015 Aug;6(4):351. doi: 10.4172/2155-9899.1000351. Epub 2015 Aug 26. J Clin Cell Immunol. 2015. PMID: 26807308 Free PMC article.
-
Induction of apoptosis and immune response by all-trans retinoic acid plus interferon-gamma in human malignant glioblastoma T98G and U87MG cells.Cancer Immunol Immunother. 2007 May;56(5):615-25. doi: 10.1007/s00262-006-0219-6. Epub 2006 Sep 1. Cancer Immunol Immunother. 2007. PMID: 16947022 Free PMC article.
-
Enhancement of HLA class II-restricted CD4+ T cell recognition of human melanoma cells following treatment with bryostatin-1.Cell Immunol. 2011;271(2):392-400. doi: 10.1016/j.cellimm.2011.08.007. Epub 2011 Aug 18. Cell Immunol. 2011. PMID: 21903207 Free PMC article.
-
Absence of gamma-interferon-inducible lysosomal thiol reductase in melanomas disrupts T cell recognition of select immunodominant epitopes.J Exp Med. 2002 May 20;195(10):1267-77. doi: 10.1084/jem.20011853. J Exp Med. 2002. PMID: 12021307 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials